Related Experiment Videos
Safety and tolerance of ocular administration of recombinant alpha interferon
R B Turner1, F J Durcan, J K Albrecht
1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132.
Antimicrobial Agents and Chemotherapy
|March 1, 1989
Abstract:
The safety, tolerance, and levels of drug in the nasal cavity produced by an ocular formulation of interferon were determined at four dosages in a placebo-controlled, double-masked trial. Interferon given by the ocular route was generally well tolerated, although a dose-related occurrence of subjective symptoms was detected.